Fig. 4From: Comparing the benefits of chemoradiotherapy and chemotherapy for resectable stage III A/N2 non-small cell lung cancer: a meta-analysisa Forest plot comparing the incidence of patients who did not have surgery after neoadjuvant therapy in chemotherapy and chemoradiotherapy groups. b Forest plot comparing the incidence of patients not receiving surgery due to progression disease in two groups. c Forest plot comparing the incidence of patients not receiving surgery due to neoadjuvant therapy related toxicity in two groupsBack to article page